CDC committee votes to resume Johnson & Johnson COVID-19 vaccine despite possible blood clot link
Coronavirus,Coronavirus Vaccine
From the Right
AllSides Media Bias Rating: Right
A Centers for Disease Control and Prevention (CDC) advisory committee is recommending that the Johnson & Johnson COVID-19 vaccine resume rollout, but include new language on the product’s emergency use authorization (EUA) warning remote risks of serious blood clots. The Advisory Committee on Immunization Practices held the vote Friday after the FDA and CDC had recommended a pause in the Johnson & Johnson COVID-19 vaccine rollout last week due to several instances of a rare, severe blood clot amid a backdrop of over 7 million recipients.
The vote was 10 to 4.
One committee member abstained.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
ICE Detains Conservative Influencer Milo Yiannopoulos in Louisiana
August 28th, 2026
Headline Roundup
USAID Report Claims Over 100 UNRWA Employees Participated in October 7 Attacks
August 28th, 2026
Bias
Will Data Centers Create Blackouts? Examining Media Bias and Misinformation on The Tucker Carlson Show
Julie Mastrine
August 28th, 2026
